SR

Sartorius Aktiengesellschaft (SRT3)

HealthcareMedical Instruments & Supplies
224.70EUR
+0.63%
Magic Rank
#38
Earnings Yield
3.4%
Return on Capital
> 999%
Market Cap
15.4B

Performance vs S&P 500 (5Y)

SRT3.XETRA
S&P 500

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Magic Formula Analysis

Enterprise Value19B
Market / Universe
de
Germany

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio95.60
Dividend Yield0.3%
Debt to Equity1.31
Gross Margin17.1%